We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
(-2.6%)
Cap. Flow
-$4.15B
Cap. Flow
% of AUM
-9.34%
Top 10 Holdings %
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$309M |
| 2 |
ExxonMobil
XOM
|
+$302M |
| 3 |
Amazon
AMZN
|
+$291M |
| 4 |
Citigroup
C
|
+$253M |
| 5 |
Shopify
SHOP
|
+$238M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$383M |
| 2 |
Johnson & Johnson
JNJ
|
+$312M |
| 3 |
JPMorgan Chase
JPM
|
+$285M |
| 4 |
AT&T
T
|
+$191M |
| 5 |
Dollar General
DG
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.63% |
| 2 | Financials | 15.61% |
| 3 | Technology | 14.28% |
| 4 | Consumer Discretionary | 13.21% |
| 5 | Industrials | 5.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Flywire
FLYW
$1.96B
| $49.5M | 0.11% |
2,024,647
-235,305
| -10% | -$5.07M |
|
202
argenx
ARGX
$57.4B
| $49.5M | 0.11% |
130,660
+29,428
| +29% | +$11M |
|
203
Yum China
YUMC
$14.9B
| $49.4M | 0.11% |
894,490
-121,552
| -12% | -$6.18M |
|
204
Mobileye
MBLY
$2.03B
| $48.6M | 0.11% |
+1,386,686
| New | +$42.1M |
|
205
Zscaler
ZS
$23B
| $47.6M | 0.11% |
425,283
-28,656
| -6% | -$3.89M |
|
206
Entegris
ENTG
$19.7B
| $46.8M | 0.11% |
714,136
-183,099
| -20% | -$13.5M |
|
207
Outfront Media
OUT
$5.64B
| $46.8M | 0.11% |
2,866,573
+399,137
| +16% | +$6.74M |
|
|
208
AT&T
T
$165B
| $46.8M | 0.11% |
2,540,460
-10,685,778
| -81% | -$191M |
|
|
TGNA
209
DELISTED
TEGNA Inc
TGNA
| $46.5M | 0.1% |
2,194,696
+998,311
| +83% | +$20.1M |
|
210
Cytokinetics
CYTK
$11B
| $46.3M | 0.1% |
1,011,462
+55,576
| +6% | +$2.39M |
|
|
WCC
211
WESCO International
WCC
$16.2B
| $46.2M | 0.1% |
369,255
+291,564
| +375% | +$36.7M |
|
|
212
PUT
Johnson & Johnson
JNJ
$635B
| $46.2M | 0.1% |
261,500
+147,800
| +130% | +$25.5M |
|
213
MSCI
MSCI
$40B
| $45.9M | 0.1% |
98,777
-124,428
| -56% | -$57.9M |
|
214
MasTec
MTZ
$26.7B
| $45.9M | 0.1% |
538,066
-153,893
| -22% | -$12.6M |
|
215
GlobalFoundries
GFS
$29.4B
| $45.8M | 0.1% |
849,022
-1,112,243
| -57% | -$65M |
|
216
HEICO Corp
HEI
$48.9B
| $45.3M | 0.1% |
294,865
+174,284
| +145% | +$27.1M |
|
|
MPT
217
Medical Properties Trust
MPT
$2.89B
| $44.8M | 0.1% |
4,022,524
-3,081,527
| -43% | -$35.8M |
|
218
New Oriental
EDU
$7.84B
| $44.7M | 0.1% |
+1,284,123
| New | +$36.3M |
|
219
CALL
VanEck Semiconductor ETF
SMH
$67.6B
| $44.4M | 0.1% |
437,600
-220,000
| -33% | -$22.4M |
|
220
Air Products & Chemicals
APD
$66.3B
| $44.3M | 0.1% |
+143,621
| New | +$40.5M |
|
221
ServiceNow
NOW
$102B
| $44.2M | 0.1% |
569,265
+492,410
| +641% | +$38.5M |
|
222
STMicroelectronics
STM
$46B
| $44.1M | 0.1% |
+1,240,088
| New | +$43.7M |
|
223
Autodesk
ADSK
$44.3B
| $44.1M | 0.1% |
235,987
+229,558
| +3,571% | +$46.1M |
|
224
Performance Food Group
PFGC
$17.5B
| $43.8M | 0.1% |
749,832
-399,945
| -35% | -$21.8M |
|
|
X
225
DELISTED
US Steel
X
| $43.7M | 0.1% |
1,745,446
-1,066,525
| -38% | -$24.6M |
|
Similar funds
Marshall Wace's Q4 2022 Portfolio in Review
As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.
Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.
- Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
- Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
- Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
- Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
- Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
- Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
- Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.
Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.